Which HIV prevention shot do patients prefer? new study aims to find out
Knowledge-focused
Not yet recruiting
This study will survey 128 adults in Louisville, Kentucky who are already taking or starting a long-acting injectable HIV PrEP shot. Participants will answer questionnaires about their satisfaction and adherence to either lenacapavir or cabotegravir over 12 months. The goal is to…
Sponsor: Anupama Raghuram MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC